BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Cash flow
Market cap
$11.03M
P/E ratio
| 2011/12 | 2012/12 | 2013/12 | 2014/12 | 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | 2025/12 | |
| Stock-based compensation | 7 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cash from operations | -2 | -3 | -4 | -4 | -7 | -6 | -2 | -12 | -11 | -35 | -26 | -19 | -20 | -9 | -7 |
| Capital expenditures | -1 | -1 | -1 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | - |
| Cash from investing | -0 | -3 | 3 | -4 | -11 | 6 | 4 | -1 | 6 | -4 | 0 | 1 | 2 | 0 | - |
| Repurchases of common stock | - | - | - | - | - | - | - | - | - | 0 | - | - | - | - | - |
| Cash from financing | 14 | 20 | 23 | 10 | 15 | - | 0 | 12 | 5 | 77 | 7 | 0 | 19 | 8 | 7 |
| Free cash flow | - |